Defining criteria for disease activity states in systemic juvenile idiopathic arthritis based on the systemic Juvenile Arthritis Disease Activity Score
Silvia Rosina,Ana I. Rebollo‐Gimenez,Letizia Tarantola,Angela Pistorio,Yulia Vyzhga,Yasser El Miedany,Hala M. Lotfy,Hend Abu‐Shady,Mervat Eissa,Naglaa S. Osman,Waleed Hassan,Marwa Y. Mahgoub,Nermeen A. Fouad,Doaa M. Mosa,Yasmin Adel,Sheren E. M. Mohamed,Ahmed R. Radwan,Mohamed H. Abu‐Zaid,Samar A. A. Tabra,Radwa H. Shalaby,Samah I. Nasef,Raju Khubchandani,Archana Khan,Naziya P. Maldar,Seza Ozen,Yagmur Bayindir,Motasem Alsuweiti,Raed Alzyoud,Hiba Almaaitah,Soamarat Vilaiyuk,Butsabong Lerkvaleekul,Ekaterina Alexeeva,Tatyana Dvoryakovskaya,Ivan Kriulin,Claudia Bracaglia,Manuela Pardeo,Fabrizio De Benedetti,Francesco Licciardi,Davide Montin,Francesca Robasto,Francesca Minoia,Giovanni Filocamo,Martina Rossano,Gabriele Simonini,Edoardo Marrani,Sarah Abu‐Rumeleih,Mikhail M. Kostik,Konstantin E. Belozerov,Priyankar Pal,Jigna N. Bathia,María M. Katsicas,Giselle Villarreal,Achille Marino,Stefania Costi,Flavio Sztajnbok,Rodrigo M. Silva,Maria C. Maggio,Dalia H. El‐Ghoneimy,Rasha El Owaidy,Adele Civino,Federico Diomeda,Sulaiman M. Al‐Mayouf,Fuad Al‐Sofyani,Zane Dāvidsone,Elisa Patrone,Claudia Saad‐Magalhães,Alessandro Consolaro,Angelo Ravelli
DOI: https://doi.org/10.1002/art.42865
2024-05-01
Arthritis & Rheumatology
Abstract:Objective To develop and validate cutoff values in the systemic Juvenile Arthritis Disease Activity Score 10 (sJADAS10) that distinguish the states of inactive disease (ID), minimal disease activity (MiDA), moderate disease activity (MoDA), and high disease activity (HDA) in children with systemic juvenile idiopathic arthritis (sJIA), based on subjective disease state assessment by the treating pediatric rheumatologist. Methods The cutoffs definition cohort was composed of 400 patients enrolled at 30 pediatric rheumatology centers in 11 countries. Using the subjective physician rating as an external criterion, 6 methods were applied to identify the cutoffs: mapping, calculation of percentiles of cumulative score distribution, Youden index, 90% specificity, maximum agreement, and ROC curve analysis. Sixty percent of the patients were assigned to the definition cohort and 40% to the validation cohort. Cutoff validation was conducted by assessing discriminative ability. Results The sJADAS10 cutoffs that separated ID from MiDA, MiDA from MoDA, and MoDA from HDA were ≤ 2.9, ≤ 10, and > 20.6. The cutoffs discriminated strongly among different levels of pain, between patients with or without morning stiffness, and between patients whose parents judged their disease status as remission or persistent activity/flare or were satisfied or not satisfied with current illness outcome. Conclusion The sJADAS cutoffs revealed good metrologic properties in both definition and validation cohorts, and are therefore suitable for use in clinical trials and routine practice.
rheumatology